These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1060 related items for PubMed ID: 17377079

  • 21. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.
    Zemljic G, Bunc M, Yazdanbakhsh AP, Vrtovec B.
    J Card Fail; 2007 Aug; 13(6):417-21. PubMed ID: 17675054
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone.
    Rieg AD, Schroth SC, Grottke O, Hein M, Ackermann D, Rossaint R, Schälte G.
    Eur J Anaesthesiol; 2009 Nov; 26(11):946-53. PubMed ID: 19687740
    [Abstract] [Full Text] [Related]

  • 24. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
    Ponschab M, Hochmair N, Ghazwinian N, Mueller T, Plöchl W.
    Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Experiences of levosimendan as an inotropic agent in conjunction with passive containment surgery.
    Bredin F, Franco-Cereceda A.
    Scand Cardiovasc J; 2007 Jun; 41(3):197-200. PubMed ID: 17487771
    [Abstract] [Full Text] [Related]

  • 27. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery.
    Feneck RO, Sherry KM, Withington PS, Oduro-Dominah A, European Milrinone Multicenter Trial Group.
    J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):306-15. PubMed ID: 11426360
    [Abstract] [Full Text] [Related]

  • 28. Timing of levosimendan in cardiac surgery.
    Aksun M, Karahan N, Adanir T, Aran G, Yetkin U, Oztürk T, Sencan A, Ozgürbüz U, Gürbüz A.
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):223-30. PubMed ID: 19520657
    [Abstract] [Full Text] [Related]

  • 29. Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: comparison of patients with a low and high prebypass cardiac index.
    Yamada T, Takeda J, Katori N, Tsuzaki K, Ochiai R.
    J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):367-73. PubMed ID: 10972598
    [Abstract] [Full Text] [Related]

  • 30. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Oner E, Erturk M, Birant A, Kurtar Mansıroglu A, Akturk IF, Karakurt H, Yalcin AA, Uzun F, Somuncu MU, Yildirim A.
    Cardiol J; 2015 Aug; 22(1):87-93. PubMed ID: 24846511
    [Abstract] [Full Text] [Related]

  • 31. New positive inotropic agents in the treatment of left ventricular dysfunction.
    De Luca L, Proietti P, Palombaro GL, Battagliese A, Celotto A, Bucciarelli Ducci C, Fedele F.
    Ital Heart J; 2004 Jun; 5 Suppl 6():63S-67S. PubMed ID: 15185917
    [Abstract] [Full Text] [Related]

  • 32. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery.
    Tritapepe L, De Santis V, Vitale D, Guarracino F, Pellegrini F, Pietropaoli P, Singer M.
    Br J Anaesth; 2009 Feb; 102(2):198-204. PubMed ID: 19151048
    [Abstract] [Full Text] [Related]

  • 33. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure.
    Segreti JA, Marsh KC, Polakowski JS, Fryer RM.
    J Pharmacol Exp Ther; 2008 Apr; 325(1):331-40. PubMed ID: 18171907
    [Abstract] [Full Text] [Related]

  • 34. Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
    Mishra A, Kumar B, Dutta V, Arya VK, Mishra AK.
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):639-46. PubMed ID: 27321790
    [Abstract] [Full Text] [Related]

  • 35. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery.
    Erb J, Beutlhauser T, Feldheiser A, Schuster B, Treskatsch S, Grubitzsch H, Spies C.
    J Int Med Res; 2014 Jun; 42(3):750-64. PubMed ID: 24781725
    [Abstract] [Full Text] [Related]

  • 36. Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting.
    Akgul A, Mavioglu L, Katircioglu SF, Pac M, Cobanoglu A.
    Heart Lung Circ; 2006 Oct; 15(5):320-4. PubMed ID: 16860605
    [Abstract] [Full Text] [Related]

  • 37. Levosimendan compared with dobutamine in low output patients.
    Nieminen MS.
    Minerva Anestesiol; 2003 Apr; 69(4):258-63. PubMed ID: 12766717
    [Abstract] [Full Text] [Related]

  • 38. Management of acute cardiac failure by intracoronary administration of levosimendan.
    Caimmi PP, Kapetanakis EI, Beggino C, Molinari C, Giustini G, Crosio E, Reposo G, Micalizzi E, Vacca G, Grossini E.
    J Cardiovasc Pharmacol; 2011 Sep; 58(3):246-53. PubMed ID: 21654504
    [Abstract] [Full Text] [Related]

  • 39. Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial.
    Momeni M, Rubay J, Matta A, Rennotte MT, Veyckemans F, Poncelet AJ, Clement de Clety S, Anslot C, Joomye R, Detaille T.
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):419-24. PubMed ID: 20829069
    [Abstract] [Full Text] [Related]

  • 40. Effect of levosimendan and milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogs.
    Papp JG, Pollesello P, Varró AF, Végh AS.
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):129-35. PubMed ID: 16891290
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.